Search results

Order by most recent / most popular / relevance

Results: 1-10 of 732

Supreme Court declines to hear Eli Lilly’s “promise of the patent” appeal

Bereskin & Parr LLP
-
Canada
-
May 16 2013

The Supreme Court of Canada denied leave to appeal today from the Federal Court of Appeal ("FCA") decision in Eli Lilly Canada Inc v Novopharm Ltd

What goes upmust come down: Viagra patent invalidated by Canadian Supreme Court

Drinker Biddle & Reath LLP
-
Canada
-
May 13 2013

Pfizer and Teva have been fighting a legal battle over Pfizer's patent for Viagra in Canada. The first shot was fired when Novopharm Limited, now

Two recent US court decisions deal with the boundaries of patent law in the area of food technologies and computer systems

Bereskin & Parr LLP
-
Canada
-
May 21 2013

The US Federal Circuit Court of Appeals and US Supreme Court have both issued important decisions this week on the scope of US patent law. Ten (10

Patent exhaustion does not allow a purchaser to make new copies of patented seeds

Fasken Martineau DuMoulin LLP
-
Canada
-
May 16 2013

In a concise unanimous decision1, the Supreme Court of the United States has ruled in favor of Monsanto against a farmer who reproduced patented

Dispelling the Myriad gene patent harmonization myth

Foley & Lardner LLP
-
Australia, Canada, European Union, France, Germany, Japan, USA
-
April 30 2013

In the wake of the Supreme Court oral arguments in the Myriad "gene patent" case, most commentators are predicting that the Court will uphold the

Prohibition not granted as non-infringement allegation held justified

Borden Ladner Gervais LLP
-
Canada
-
July 18 2012

The Court heard this application and the next application consecutively and issued decisions on the same day, however, indicated that each was considered separately

Generic ordered to pay $1.7 million in accounting of profits

Gowling Lafleur Henderson LLP
-
Canada
-
April 22 2013

On March 12, 2013, the Federal Court released its decision in Apotex Inc. v. H. Lundbeck AS, 2013 FC 192. The Court dismissed Apotex's action to

Mylan Pharmaceuticals ULC v. Pfizer Canada Inc., 2012 FCA 103 - Aricept (donepezil), appeal of NOC case

Gowling Lafleur Henderson LLP
-
Canada
-
April 3 2012

The Court of Appeal upheld on Order prohibiting the Minister of Health from issuing a NOC to Mylan for donepezil, a drug for the treatment of Alzheimer's type dementia, until expiry of Pfizer’s ‘808 Patent

Intellectual property weekly abstracts bulletin

Borden Ladner Gervais LLP
-
Canada, USA
-
May 22 2013

The Supreme Court has dismissed Eli Lilly of Canada Inc.’s leave on the issue, as summarized by the Court, as to whether the creation by the Federal

USTR slams Canada over the treatment of pharmaceutical patents

Norton Rose Canada LLP
-
Canada
-
May 6 2013

On May 1, 2013, the United States Trade Representative (“USTR”) released its annual IP report for 2013. Canada has been placed on the “Watch List"

next >

Search results

Supreme Court declines to hear Eli Lilly’s “promise of the patent” appeal

What goes upmust come down: Viagra patent invalidated by Canadian Supreme Court

Two recent US court decisions deal with the boundaries of patent law in the area of food technologies and computer systems

Patent exhaustion does not allow a purchaser to make new copies of patented seeds

Dispelling the Myriad gene patent harmonization myth

Prohibition not granted as non-infringement allegation held justified

Generic ordered to pay $1.7 million in accounting of profits

Mylan Pharmaceuticals ULC v. Pfizer Canada Inc., 2012 FCA 103 - Aricept (donepezil), appeal of NOC case

Intellectual property weekly abstracts bulletin

USTR slams Canada over the treatment of pharmaceutical patents

Current Search

Suggested Facets

Author

Firm Name

Jurisdiction

Workarea